MISSISSAUGA, ON, March 3, 2016 /PRNewswire/ - Cipher
Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the
Company") today announced that Shawn
Patrick O'Brien, President and Chief Executive Officer, will
present at two upcoming investor conferences.
- The 36th Annual Cowen and Company Health Care Conference in
Boston on March 8, 2016
at 9:15 a.m. ET.
- The 28th Annual ROTH Conference in Orange County on
Tuesday, March 15, 2016
at 3:30 p.m. PT.
Both conference presentations will be webcast live. To access
the webcasts, please go to the Investors section of the Company's
website at www.cipherpharma.com under the Events &
Webcasts tab.
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly
growing specialty pharmaceutical dermatology company with a
diversified portfolio of commercial-stage products with the goal of
becoming the most customer-centric dermatology company
in North America.
Cipher completed seven transactions in 2015, including the
acquisition of Innocutis and its nine branded dermatology products,
to build its U.S. commercial presence, expand its Canadian
dermatology franchise and broaden its pipeline. Cipher is
well-capitalized to drive long-term, sustained earnings growth by
leveraging its proven clinical development capabilities and
efficient commercial execution. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.